Understand the importance of developing your clinical strategy early in the drug development process. This exclusive workshop is focused on Canadian and International Reimbursement Strategies and will be lead by Allan Miranda, Therapeutic Lead, Reimbursement and Market Access, and Lois Mitchell, Director, New Product Development with Janssen Pharmaceutical Companies of Johnson & Johnson.
Back to All Events
Earlier Event: November 11
Insider Insights Tom Reeves, OBIO Director and President & Chief Executive Officer of Interface Biologics.
Later Event: January 31
OBIO® EXECUTIVE EXCHANGE SERIES: TACKLING THE TERM SHEET